NCT02038738View on ClinicalTrials.gov

68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

March 31, 2019

Conditions
NeuroendocrineNeuroendocrine TumorNeuroendocrine CancerNeuroendocrine CarcinomaCarcinoidCarcinoid TumorIslet Cell TumorApudoma
Interventions
DRUG

68Ga-DOTATATE will be given in tracer doses and injected intravenously to image tumors by Positron Emission Tomography.

Trial Locations (1)

70065

Ochsner Medical Center - Kenner, Kenner

Sponsors
All Listed Sponsors
lead

Ochsner Health System

OTHER